United States · FDA National Drug Code directory
ENSACOVE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83076-1025_17196ce1-224e-4359-ac54-39e035def74f
- Product NDC
- 83076-1025
- Form
- CAPSULE
- Composition / generic term
- ensartinib
- Labeler
- Xcovery Holdings, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250430
- Source listing expiry
- 20271231
Source-listed ingredients
- ENSARTINIB HYDROCHLORIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (83076-1025-3) · 83076-1025-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →